RxDoctor Payments Data

Kathleen Kelley, MD

Dermatology · South Bend, INNPI 1245626225

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.3% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 31.7% of the total. 2025 is the largest year on record at $818, 6.0 times the $137 reported in 2019. That places this record below the midpoint for dermatology clinicians in IN, where the typical reported total is $3,818.

$2,374in general payments, 2019–2025

Across 128 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$751
  • Johnson & Johnson$279
  • Novartis$237
  • Galderma Laboratories, L.p.$162
  • Sanofi$144
  • E.r. Squibb & Sons, L.L.C.$115
  • plus $686 from 21 others

What the payments were for

  • Food & beverage$2,16791%
  • Education$2069%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,374 in reported general payments places this provider in the 40th percentile of 202 dermatology providers in Indiana.

See all dermatology providers in Indiana →

Medicare billing

Part B allowed, 2024
$200,912
Medicare patients
708
Services billed
3,405

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab40$154,987
Clobetasol Propionate113$4,525
Tacrolimus30$4,379
Fluorouracil41$3,750
Ketoconazole132$2,372
Doxycycline Monohydrate32$1,496
Tretinoin11$1,197
Triamcinolone Acetonide109$1,191
Metronidazole22$995
Clindamycin Phosphate16$718
ValacyclovirValacyclovir Hcl21$573
Hydroxychloroquine Sulfate13$567
Betamethasone Dipropionate12$538
Doxycycline Hyclate12$472
Mometasone Furoate14$310

Paid to pharmacies, not to this prescriber.

Other dermatology in South Bend

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →